Walleye Capital LLC Novartis Ag Put Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$106.13 - $120.89 $5.38 Million - $6.13 Million	50,700 Added 35.88%	192,000 $22.1 Million
Q2 2024 Aug 14, 2024	BUY	$92.57 - $107.37 $3.12 Million - $3.62 Million	33,700 Added 31.32%	141,300 $15 Million
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $15.9 Million - $18.1 Million	-166,700 Reduced 60.77%	107,600 $10.4 Million
Q4 2023 Feb 14, 2024	BUY	$92.27 - $101.54 $9.18 Million - $10.1 Million	99,500 Added 56.92%	274,300 $27.7 Million
Q3 2023 Nov 14, 2023	BUY	$94.73 - $105.13 $9.2 Million - $10.2 Million	97,100 Added 124.97%	174,800 $17.8 Million
Q2 2023 Aug 14, 2023	BUY	$92.52 - $104.91 $5.03 Million - $5.71 Million	54,400 Added 233.48%	77,700 $7.84 Million
Q1 2023 May 15, 2023	BUY	$80.03 - $92.81 $1.86 Million - $2.16 Million	23,300 New	23,300 $2.14 Million

1,437

131M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $209B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.